[1]Joshi R,Kamat JP,Mukherjee T. Free radical scavenging reactions and antioxidant activity of embelin: biochemical and pulse radiolytic studies[J].Chem Biol Interact,2007,167(2):125-134.
[2]Ahn KS, Sethi G, Aggarwal BB. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products[J]. Mol Pharmacol,2007,71(1):209-219.
[3]Hu R, Zhu K, Li Y,et al. Embelin induces apoptosis through down-regulation of XIAP in human leukemia cells[J].Med Oncol,2011,28(4):1584-1588.
[4]Nikolovska-Coleska Z, Xu L, Hu Z,et al. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database[J]. J Med Chem,2004,47(10):2430-2440.
[5]Demchenko YN, Kuehl WM.A critical role for the NFκB pathway in multiple myeloma[J].Oncotarget,2010,1(1):59-68.
[6]Casabonne D, Reina O, Benavente Y, et al. Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph[J].Haematologica,2011,96(2):323-327.
[7]Russo LA, Peano BJ, Trivedi SP,et al. Regulated expression of matrix metalloproteinases, inflammatory mediators, and endometrial matrix remodeling by 17beta-estradiol in the immature rat uterus[J].Reprod Biol Endocrinol,2009,7:124.
[8]Kruizinga RC, de Jonge HJ, Kampen KR,et al.Vascular endothelial growth factor a isoform mRNA expression in pediatric acute myeloid leukemia[J].Pediatr Blood Cancer,2011,56(2):294-297.
[9]Shanafelt T, Zent C, Byrd J, et al.Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia[J]. Leuk Lymphoma,2010,51(12):2222-2229.(编校:张志明)